The Effects of Guanfacine on Context Processing Abnormalities in Schizotypal Personality Disorder

Biological Psychiatry

Volumn 61, Issue 10, 2007, Pages 1157-1160

  McClure, Margaret M ^a   Barch, Deanna M ^b   Romero, Michelle J ^a   Minzenberg, Michael J ^d   Triebwasser, Joseph ^a   Harvey, Philip D ^a,c   Siever, Larry J ^a,c,e  

^a Clinical Microbiology Center   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cognition; guanfacine; pharmacology; Schizophrenia; Schizotypal; working memory

Indexed keywords

GUANFACINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFECT; FALSE POSITIVE RESULT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOTYPAL PERSONALITY DISORDER; SCORING SYSTEM; TASK PERFORMANCE; WORKING MEMORY;

EID: 34247622347     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.06.034     Document Type: Article

References (18)

1. Arnsten A.F.T. Adrenergic targets for the treatment of cognitive deficits in schizophrenia. Psychopharmacology (Berl) 174 (2004) 25-31
2. Barch D.M., Carter C.S., Braver T.S., Sabb F.W., MacDonald III A., Noll D.C., et al. Selective deficits in prefrontal cortex regions in medication naive schizophrenia patients. Arch Gen Psychiatry 50 (2001) 280-288
3. Barch D.M., Carter C.S., MacDonald III A.W., Braver T.S., and Cohen J.D. Context processing deficits in schizophrenia: Diagnostic specificity, 4-week course, and relationships to clinical symptoms. J Abnorm Psychol 112 (2003) 132-143
4. Barch D.M., Mitropoulou V., Harvey P.D., New A.S., Silverman J.M., and Siever L.J. Context-processing deficits in schizotypal personality disorder. J Abnorm Psychol 113 (2004) 556-568
5. Braver T.S., Barch D.M., and Cohen J.D. Cognition and control in schizophrenia: A computational model of dopamine and prefrontal function. Biol Psychiatry 46 (1999) 312-328
6. Braver T.S., and Cohen J.D. Dopamine, cognitive control, and schizophrenia: The gating model. Prog Brain Res 121 (1999) 327-349
7. Cadenhead K.S., Perry W., Shafer K., and Braff D.L. Cognitive functions in schizotypal personality disorder. Schizophr Res 25 (1999) 123-132
8. Cohen J.D., Barch D.M., Carter C., and Servan-Schreiber D. Context-processing deficits in schizophrenia: Converging evidence from three theoretically motivated cognitive tasks. J Abnorm Psychol 108 (1999) 120-133
9. Cohen J.D., and Servan-Schreiber D. Context, cortex and dopamine: A connectionist approach to behavior and biology in schizophrenia. Psychol Rev 99 (1992) 45-77
10. Friedman J.L., Adler D.N., and Davis K.L. The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease. Biol Psychiatry 46 (1999) 1243-1252
11. Friedman J.L., Adler D.N., Temporini H.D., Kemether E., Harvey P.D., White L., et al. Guanfacine treatment of cognitive impairment in schizophrenia. Neuropsychopharmacology 25 (2001) 402-409
12. Heinrichs R.W. The primacy of cognition in schizophrenia. Am Psychol 60 (2005) 229-242
13. Mitropoulou V., Harvey P.D., Zegarelli G., New A.S., Silverman J.M., and Siever L.J. Neuropsychological performance in schizoypal personality disorder: importance of working memory. Am J Psychiatry 162 (2005) 1986-903
14. Moritz S., and Mass R. Reduced cognitive inhibition in schizotypy. Br J Clin Psychol 36 (1997) 365-376
15. Roitman S.E., Mitropoulou V., Keefe R.S., Silverman J.M., Serby M., Harvey P.D., et al. Visuospatial working memory in schizotypal personality disorder patients. Schizophr Res 41 (2000) 447-455
16. Roitman S.E.L., Cornblatt B.A., Bergman A., Obuchowski M., Mitropoulou V., Keefe R.S., et al. Attentional functioning in schizotypal personality disorder. Am J Psychiatry 154 (1997) 655-660
17. Siever L.J., Kalus O., and Keefe R.S. The boundaries of schizophrenia. Psychiatr Clin North Am 16 (1993) 217-244
18. Voglmaier M., Seidman L.J., Salisbury D., and McCarley R.W. Neuropsychological dysfunction in schizotypal personality disorder: A profile analysis. Biol Psychiatry 41 (1997) 530-540